Literature DB >> 26359649

Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Zhiyan Xiao1,2, Susan L Morris-Natschke3, Kuo-Hsiung Lee3,4.   

Abstract

Natural products have made significant contribution to cancer chemotherapy over the past decades and remain an indispensable source of molecular and mechanistic diversity for anticancer drug discovery. More often than not, natural products may serve as leads for further drug development rather than as effective anticancer drugs by themselves. Generally, optimization of natural leads into anticancer drugs or drug candidates should not only address drug efficacy, but also improve absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles and chemical accessibility associated with the natural leads. Optimization strategies involve direct chemical manipulation of functional groups, structure-activity relationship directed optimization and pharmacophore-oriented molecular design based on the natural templates. Both fundamental medicinal chemistry principles (e.g., bioisosterism) and state-of-the-art computer-aided drug design techniques (e.g., structure-based design) can be applied to facilitate optimization efforts. In this review, the strategies to optimize natural leads to anticancer drugs or drug candidates are illustrated with examples and described according to their purposes. Furthermore, successful case studies on lead optimization of bioactive compounds performed in the Natural Products Research Laboratories at UNC are highlighted.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  anticancer drugs; lead optimization; natural products

Mesh:

Substances:

Year:  2015        PMID: 26359649      PMCID: PMC4679534          DOI: 10.1002/med.21377

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  228 in total

1.  BN 80927: a novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II.

Authors:  O Lavergne; J Harnett; A Rolland; C Lanco; L Lesueur-Ginot; D Demarquay; M Huchet; H Coulomb; D C Bigg
Journal:  Bioorg Med Chem Lett       Date:  1999-09-06       Impact factor: 2.823

2.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-10-04       Impact factor: 15.336

3.  Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate.

Authors:  D J Chaplin; G R Pettit; S A Hill
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

4.  Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.

Authors:  E J Martinez; T Owa; S L Schreiber; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

6.  Antitumor activity of phenylahistin in vitro and in vivo.

Authors:  K Kanoh; S Kohno; J Katada; Y Hayashi; M Muramatsu; I Uno
Journal:  Biosci Biotechnol Biochem       Date:  1999-06       Impact factor: 2.043

Review 7.  Novel antitumor agents from higher plants.

Authors:  K H Lee
Journal:  Med Res Rev       Date:  1999-11       Impact factor: 12.944

8.  Total synthesis of epothilone E and related side-chain modified analogues via a Stille coupling based strategy.

Authors:  K C Nicolaou; N P King; M R Finlay; Y He; F Roschangar; D Vourloumis; H Vallberg; F Sarabia; S Ninkovic; D Hepworth
Journal:  Bioorg Med Chem       Date:  1999-05       Impact factor: 3.641

Review 9.  Uracil mustard revisited.

Authors:  B J Kennedy; J L Torkelson; E Torlakovic
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

10.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.

Authors:  L Meng; R Mohan; B H Kwok; M Elofsson; N Sin; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

View more
  26 in total

Review 1.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

2.  Re-engineering natural products to engage new biological targets.

Authors:  Stephen E Motika; Paul J Hergenrother
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

3.  Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents.

Authors:  Garima Priyadarshani; Anmada Nayak; Suyog M Amrutkar; Sarita Das; Sankar K Guchhait; Chanakya N Kundu; Uttam C Banerjee
Journal:  ACS Med Chem Lett       Date:  2016-09-20       Impact factor: 4.345

4.  Broccoli extract improves chemotherapeutic drug efficacy against head-neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ramy Ashry; Ghada Abu Elghanam; Hieu M Pham; Xinyun Su; Camille Stegen; Simon D Tran
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

5.  Identification of a 3-β-homoalanine conjugate of brusatol with reduced toxicity in mice.

Authors:  Nicky Hwang; Yonggang Pei; Jason Clement; Erle S Robertson; Yanming Du
Journal:  Bioorg Med Chem Lett       Date:  2020-09-21       Impact factor: 2.823

6.  Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.

Authors:  Xiao-Ru Zhang; Hao-Wen Wang; Wen-Lin Tang; Yu Zhang; Hui Yang; De-Xuan Hu; Azhar Ravji; Christophe Marchand; Evgeny Kiselev; Kwabena Ofori-Atta; Keli Agama; Yves Pommier; Lin-Kun An
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

7.  Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors.

Authors:  Yu Zhao; Chin-Ho Chen; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Eur J Med Chem       Date:  2021-02-14       Impact factor: 6.514

Review 8.  PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.

Authors:  Lennox Chitsike; Penelope J Duerksen-Hughes
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

9.  Polymethoxyselenoflavones exert anti-obesity effects through activation of lipolysis and brown adipocyte metabolism.

Authors:  Hyun-Jung Kwon; Abhirup Saha; Sang-Yeop Ahn; Yoon Keun Cho; Yeonho Son; Minsu Kim; Je Kyung Seong; Woo-Ram Yang; Young-Suk Jung; Jin-Hyun Jeong; Yun-Hee Lee
Journal:  Int J Obes (Lond)       Date:  2020-05-28       Impact factor: 5.095

10.  Cheminformatic Profiling and Hit Prioritization of Natural Products with Activities against Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Samson O Oselusi; Samuel A Egieyeh; Alan Christoffels
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.